SCHEMBL15438546

SCHEMBL15438546

CC(=O)OCC(=O)N1CCCNCC1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ TPSAB1 Q15661 1/20 0.44
▸ TPSD1 Q9BZJ3 1/20 0.44
▸ TPSG1 Q9NRR2 1/20 0.44
▸ CA2 P00918 2/20 0.43
▸ CHKA P35790 1/20 0.43
▸ RAB9A P51151 8/20 0.41
▸ MAPT P10636 2/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ TP53 P04637 1/20 0.41
▸ DPP4 P27487 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ NPC1 O15118 6/20 0.37
▸ HTT P42858 1/20 0.36
▸ CA12 O43570 1/20 0.36
▸ CA1 P00915 1/20 0.36
▸ CA9 Q16790 1/20 0.36
▸ USP2 O75604 1/20 0.36
▸ MAPK1 P28482 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2904236 0.93 TPSAB1 (0.49) TPSAB1TPSD1TPSG1CA2CHKA
SCHEMBL2904241 0.93 TPSAB1 (0.49) TPSAB1TPSD1TPSG1CA2CHKA
Hydrochloric Acid SCHEMBL21752648 0.91 TPSAB1 (0.47) TPSAB1TPSD1TPSG1CA2CHKA
SCHEMBL29190317 0.91 TPSAB1 (0.51) TPSAB1TPSD1TPSG1CA2CHKA
SCHEMBL2025855 0.84 RAB9A (0.49) RAB9AMAPTALDH1A1TP53SMN1; SMN2
SCHEMBL18780592 0.84 RAB9A (0.53) RAB9AMAPTALDH1A1TP53SMN1; SMN2
SCHEMBL13996243 0.82 RAB9A (0.51) RAB9AMAPTALDH1A1TP53SMN1; SMN2
SCHEMBL22442246 0.81 TPSAB1 (0.43) TPSAB1TPSD1TPSG1CA2CHKA
Hydrochloric Acid SCHEMBL18824267 0.81 TPSAB1 (0.45) TPSAB1TPSD1TPSG1CA2CHKA
SCHEMBL31217979 0.77 TPSAB1 (0.41) TPSAB1TPSD1TPSG1CA2CHKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2885285-B1 PYRAZOLE DRIVATIVES WHICH INHIBIT LEUKOTRIENE PRODUCTION BOEHRINGER INGELHEIM INT (DE) 2016-10-19 — — EP disclosed
EP-2885285-B1 PYRAZOLE DRIVATIVES WHICH INHIBIT LEUKOTRIENE PRODUCTION BOEHRINGER INGELHEIM INT (DE) 2016-10-19 — — EP disclosed
US-9403830-B2 Inhibitors of leukotriene production BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2016-08-02 — — US disclosed
US-9403830-B2 Inhibitors of leukotriene production BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2016-08-02 — — US disclosed
US-9403830-B2 Inhibitors of leukotriene production BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2016-08-02 — — US disclosed
US-20140031339-A1 INHIBITORS OF LEUKOTRIENE PRODUCTION BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-01-30 — — US disclosed
US-20140031339-A1 INHIBITORS OF LEUKOTRIENE PRODUCTION BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-01-30 — — US disclosed
US-20140031339-A1 INHIBITORS OF LEUKOTRIENE PRODUCTION BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-01-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140031339-A1 INHIBITORS OF LEUKOTRIENE PRODUCTION LTA4H, LTB4R, LTB4R2 TPSAB1 22/4885TPSD1 201/4885TPSG1 157/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback